PURPOSE: To develop a magnetic resonance imaging (MRI) technique for assessing in vivo properties of orally ingested gastric-retentive tablets under physiologic conditions. METHODS: Tablets with different floating characteristics (tablet A-C) were marked with superparamagnetic Fe3O4 particles to analyze intragastric tablet position and residence time in human volunteers. Optimal Fe3O4 concentration was determined in vitro. Intragastric release characteristic of one slow-release tablet (tablet D) was analyzed by embedding gadolinium chelates (Gd-DOTA) as a drug model into the tablet. All volunteers underwent MRI in the sitting position. Tablet performance was analyzed in terms of relative position of tablet to intragastric meal level (with 100% at meal surface), intragastric residence time (min) and Gd-DOTA distribution volume (% of meal volume). RESULTS: Intragastric tablet floating performance and residence time of tablets (tablet A-D) as well as the intragastric Gd-DOTA distribution of tablet D could be monitored using MRI. Tablet floating performance was different between the tablets (A, 93%(95 - 9%); B, 80%(80 - 68%): C, 38%(63 - 32%); p < 0.05). The intragastric distribution volume of Gd-DOTA was 19.9% proximally and 35.5% distally. CONCLUSIONS: The use of MRI allows the assessment of galenic properties of orally ingested tablets in humans in seated position.
PURPOSE: To develop a magnetic resonance imaging (MRI) technique for assessing in vivo properties of orally ingested gastric-retentive tablets under physiologic conditions. METHODS: Tablets with different floating characteristics (tablet A-C) were marked with superparamagnetic Fe3O4 particles to analyze intragastric tablet position and residence time in human volunteers. Optimal Fe3O4 concentration was determined in vitro. Intragastric release characteristic of one slow-release tablet (tablet D) was analyzed by embedding gadolinium chelates (Gd-DOTA) as a drug model into the tablet. All volunteers underwent MRI in the sitting position. Tablet performance was analyzed in terms of relative position of tablet to intragastric meal level (with 100% at meal surface), intragastric residence time (min) and Gd-DOTA distribution volume (% of meal volume). RESULTS: Intragastric tablet floating performance and residence time of tablets (tablet A-D) as well as the intragastric Gd-DOTA distribution of tablet D could be monitored using MRI. Tablet floating performance was different between the tablets (A, 93%(95 - 9%); B, 80%(80 - 68%): C, 38%(63 - 32%); p < 0.05). The intragastric distribution volume of Gd-DOTA was 19.9% proximally and 35.5% distally. CONCLUSIONS: The use of MRI allows the assessment of galenic properties of orally ingested tablets in humans in seated position.
Authors: L Marciani; P A Gowland; R C Spiller; P Manoj; R J Moore; P Young; A J Fillery-Travis Journal: Am J Physiol Gastrointest Liver Physiol Date: 2001-06 Impact factor: 4.052
Authors: L Marciani; P Manoj; B P Hills; R J Moore; P Young; A Fillery-Travis; R C Spiller; P A Gowland Journal: J Magn Reson Date: 1998-11 Impact factor: 2.229
Authors: J Borovicka; R Lehmann; P Kunz; R Fraser; C Kreiss; G Crelier; P Boesiger; G A Spinas; M Fried; W Schwizer Journal: Am J Gastroenterol Date: 1999-10 Impact factor: 10.864
Authors: Luciana A Corá; Fernando G Romeiro; Fabiano C Paixão; Madileine F Américo; Ricardo B Oliveira; Oswaldo Baffa; José Ricardo A Miranda Journal: Pharm Res Date: 2006-08 Impact factor: 4.200